The Mevalonate Pathway: A Potential Therapeutic Target for JAK2-driven Myeloproliferative Neoplasms
The Mevalonate Pathway: A Potential Therapeutic Target for JAK2-driven Myeloproliferative Neoplasms Lori Nicole Griner Abstract Myeloproliferative neoplasms (MPNs) are diseases of hematopoietic stem cell origin and are characterized by uncontrolled growth of cells of the myeloid compartment. The Phi...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
Scholar Commons
2013
|
| Subjects: | |
| Online Access: | http://scholarcommons.usf.edu/etd/4497 http://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=5694&context=etd |